OncLiveVarious Immunotherapy Combinations Continue to Be Explored in NSCLCOncLive“We are still searching for the right combinations including immunotherapy for NSCLC,” said Daniel E. Haggstrom, MD. “We have proven efficacy as single agents and in combi… Continue reading
OncLiveVarious Immunotherapy Combinations Continue to Be Explored in NSCLCOncLive“We are still searching for the right combinations including immunotherapy for NSCLC,” said Daniel E. Haggstrom, MD. “We have proven efficacy as single agents and in combi… Continue reading
Futurity: Research News |
CRISPR knocks out ALS gene mutation in mice
Futurity: Research News For the first time, scientists have used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis, or Lou Gehrig’s disease, in mice. The therapy delayed the onset of the muscle wasting that characterizes the … |